Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
343
Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

- Cannabis Strategic Ventures’ 2020 revenue jumped 517% year-over-year to $14.6 million
- 2020 revenues from cannabis sales were $14.1 million, up 975% compared to fiscal 2019
- The company’s gross profit spiked 483% year-over-year, reaching $2.78 million in 2020, while gross margins held steady at about 20 percent
- Cannabis Strategic Ventures will launch its first Los Angeles dispensary in Q4 2021
- The company will open an indoor cultivation facility with capacity to produce up to 15,000 pounds of premium cannabis flower annually

Cannabis Strategic Ventures (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator. The company is based in Los Angeles, with a 6-acre cannabis farm in Northern California called NUGS Farm North. The company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration.

Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the City of Los Angeles and the State of California, and it is now working toward taking operational control of each license. The company also recently announced the upcoming grand opening of its cannabis dispensary, MDRN Tree. Following that launch, Cannabis Strategic Ventures intends to deploy another of its new licenses to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. The facility will have up to 1,200 grow lights and is anticipated to yield 5.75 harvests per year, bringing it to a total production capacity of over 15,000 pounds of cannabis flower annually.

Brand Portfolio

The company owns multiple brands under the Cannabis Strategic Ventures umbrella. The firm’s NUGS brand provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands.

The NUGS Farm North brand operates as a six-and-a-half-acre cannabis cultivation property located in northern California. The company believes that the key to success in its business is consistent quality and reliable supply to fit growing consumer demand. Cannabis Strategic Ventures addressed these consumer needs by building NUGS Farm North. At NUGS Farm North, the company’s process is customized, and its product is consistent. Located in the heart of an agricultural mecca for globally distributed produce, NUGS Farm North finds power in its product, not in its size. Decades of agricultural experience and a dedication to consistency ensure quality cannabis.

MDRN Tree is Cannabis Strategic Ventures’ customer-facing dispensary brand. MDRN Tree will open its first Los Angeles location sometime in the fall of 2021. MDRN Tree will be the company’s factory retail store – a direct interface with the end-market community – where Cannabis Strategic Ventures plans on showcasing the cannabis flower produced at its NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability.

Market Outlook

The demand for legal marijuana is expected to surge due to ongoing changes in U.S. state government policies toward cannabis. In addition, the number of indications for which medical marijuana is prescribed continues to increase steadily. These factors are expected to rapidly boost legal sales of cannabis products, opening new revenue channels for producers and retailers. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will only present more high growth opportunities for this market.

According to a report from Grand View Research, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a compound annual growth rate of 26.7 percent from 2021 to 2028. That CAGR would put the market value at roughly $30 billion as soon as 2025.

According to the report, “One of the major factors fueling market growth is the expanding demand for legal marijuana owing to the growing number of legal cannabis countries. (Due) to recent legalizations in different countries, the use of medical marijuana for various ailments is gaining momentum worldwide. Patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders are administered medical marijuana. The demand for cannabis oil is increasing rapidly, especially among countries with legalized medical marijuana.”

Management Team

Simon Yu is CEO, President, CFO and Secretary of Cannabis Strategic Ventures. He is also a co-founder, former COO and board member of Clubhouse Media Group Inc., a publicly traded social media company. Mr. Yu holds an MBA from the University of Southern California.

For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 1

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 1

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 2

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 1

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
XTransfer Revs Up Expansion in the UAE Market

Updated Category News Views 1

In the nitty-gritty world of B2B payments, securing a spot in a powerhouse like the UAE is no small potatoes. XTransfer just snagged an in-principle nod from the UAE Central Bank for a Retail Payment Services Licence, and that's got to feel like sweet validation for a company that's aggressively pushing its regulatory map beyond corners it's already conquered. Eyeing the...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 2

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
GoPro's $1.14 Buyout Scrutinized: Fair Value Debate

Updated Category News Views 2

Unpacking the GoPro Buyout Announcement There's some commotion brewing in the investor world, especially if you're clutching onto shares of GoPro (NASDAQ:GPRO). A $1.14 per share buyout has hit the spotlight, and folks are asking if this deal is kosher, particularly when there's $285 million on the line. Does the price truly reflect what GoPro's worth? Ademi LLP is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 5

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options

Updated Category News Views 195

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...

Continue Reading
IVX Health Celebrates Recognition as Top Workplace in Healthcare

Updated Category News Views 138

IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...

Continue Reading
NAMI Strengthens Leadership to Address Mental Health Challenges

Updated Category News Views 174

New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...

Continue Reading
In-Depth Insights into Depression Treatment Market Trends

Updated Category News Views 208

Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...

Continue Reading